Veritas In Silico Inc. (JP:130A) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Veritas In Silico Inc. is focused on expanding its platform business for mRNA-targeted drug discovery through strategic contracts and in-house pipeline creation. The company aims to enhance shareholder value by transitioning into a specialty pharmaceutical company with a balanced approach of revenue generation and investment.
For further insights into JP:130A stock, check out TipRanks’ Stock Analysis page.